Article Text

Download PDFPDF

Validation of the Saint George’s Respiratory Questionnaire in Uganda
  1. Brooks W Morgan1,2,
  2. Matthew R Grigsby1,2,
  3. Trishul Siddharthan1,2,
  4. Robert Kalyesubula3,
  5. Robert A Wise1,2,
  6. John R Hurst4,
  7. Bruce Kirenga3 and
  8. William Checkley1,2,5
  1. 1 Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  2. 2 Center for Global Non-Communicable Disease Research and Training, Johns Hopkins University, Baltimore, Maryland, USA
  3. 3 College of Health Sciences, Makerere University, Kampala, Uganda
  4. 4 UCL Respiratory, Division of Medicine, University College London, London, UK
  5. 5 Program in Global Disease Epidemiology and Control, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
  1. Correspondence to Dr William Checkley; wcheckl1{at}jhmi.edu

Footnotes

  • Contributors BWM, MRG, TS, RK, JRH, BK, WC and RAW each assisted with the study design and implementation, as well as the writing of the manuscript.

  • Funding This project was supported by NIH Research Training Grant #D43 TW009340 funded by the NIH Fogarty International Center, NINDS, NIMH, NHLBI, and NIEHS, the COPD Discovery Fund from Johns Hopkins University, and the Johns Hopkins Center for Global Health. Analysis of the validation of the SGRQ instrument in Uganda was supported in part by the Medical Research Council (MR/P008984/1, PI: Hurst).

  • Competing interests RAW reports grants and/or personal fees from AstraZeneca/Medimmune, Boehringer Ingelheim, Contrafect, GlaxoSmithKline, Pfizer, Pulmonx, Roche, Spiration, Sunovion, Teva, Pearl Therapeutics, Merck and Bonti outside the submitted work.

  • Patient consent Not required.

  • Ethics approval Johns Hopkins School of Medicine, Makerere University, Uganda National Council for Science and Technology.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Please forward requests for data to Dr Trishul Siddharthan (tsiddha1@jhmi.edu).

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors BWM, MRG, TS, RK, JRH, BK, WC and RAW each assisted with the study design and implementation, as well as the writing of the manuscript.

  • Funding This project was supported by NIH Research Training Grant #D43 TW009340 funded by the NIH Fogarty International Center, NINDS, NIMH, NHLBI, and NIEHS, the COPD Discovery Fund from Johns Hopkins University, and the Johns Hopkins Center for Global Health. Analysis of the validation of the SGRQ instrument in Uganda was supported in part by the Medical Research Council (MR/P008984/1, PI: Hurst).

  • Competing interests RAW reports grants and/or personal fees from AstraZeneca/Medimmune, Boehringer Ingelheim, Contrafect, GlaxoSmithKline, Pfizer, Pulmonx, Roche, Spiration, Sunovion, Teva, Pearl Therapeutics, Merck and Bonti outside the submitted work.

  • Patient consent Not required.

  • Ethics approval Johns Hopkins School of Medicine, Makerere University, Uganda National Council for Science and Technology.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Please forward requests for data to Dr Trishul Siddharthan (tsiddha1@jhmi.edu).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.